Vascular Technology Council

The mission of the VQI is to improve the quality, safety, effectiveness and cost of vascular health care by collecting and exchanging information. Within the SVS PSO, the goal of the Vascular Technology Council (VTC) is to provide guidance and approval for the efficient use of VQI data for the benefit of multiple stakeholders, including the FDA and industry, in order to meet regulatory requirements and aid the development of new vascular treatments.

The VTC sees great value in this collaboration and is committed to growing this network and supporting device and therapeutic innovation through the VQI.

Current VTC Members:

Scott Berman, MD, (Chair)
Jose Almeida, MD
Adam Beck, MD
Dan Claire, MD
Jack Cronenwett, MD
Chris Kwolek, MD
Jim Wadzinski (SVS PSO Staff Representative)
Ron Anson (M2S Representative)

For more information on Working with Industry and the VQI Corporate Support program, please contact Jim Wadzinski, SVS PSO General Manager, at or Ron Anson, M2S/Medstreaming Vice President of Business Development, at